Reference
Wang L, et al. Analysis of efficacy, safety and prognostic factors of dac-haa treatment in chinese pediatric patients with refractory or relapsed acute myeloid leukemia. Molecular and Clinical Oncology 15: 269, No. 6, Dec 2021. Available from: URL: http://www.spandidos-publications.com/10.3892/mco.2021.2431/download
Rights and permissions
About this article
Cite this article
Aclarubicin and antineoplastics. Reactions Weekly 1957, 15 (2023). https://doi.org/10.1007/s40278-023-39140-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-39140-6